ZIQ
BMO MSCI EAFE High Quality Index ETF

Full ZIQ fund page
VS

Suggested funds:

Select a second ETF to benchmark against BMO MSCI EAFE High Quality Index ETF (ZIQ). Compare key metrics including year-to-date performance, management fees, sector exposures and underlying assets to ensure you are selecting the best fund for your investment objectives.

NAV Performance and Flows

-1.00.01.02.03.0%Jun 17Jun 25Jul 3Jul 10Jul 17

Key Data

Compare
ZIQ
AuM$48.90 M
Management Fees0.40%
Exp. ratio0.40%
Tracking Difference-0.67%

Historical performance and flows

As of July 17, 2026
1M3MYTD1Y3Y
Perf.
ZIQ
-1.14%+3.19%+10.16%+17.93%-
Flows
ZIQ
-$21 M-$38 M-$15 M-$192 M-

Exposure

Countries

ZIQ
Switzerland
20.39%
Japan
17.89%
United Kingdom
15.75%
Netherlands
9.68%
France
7.98%
Germany
7.12%
Other
21.20%

Sectors

ZIQ
Technology
22.11%
Healthcare
21.46%
Industrials
14.66%
Consumer Non-Cyclicals
10.64%
Finance
10.61%
Non-Energy Materials
9.54%
Other
10.98%
As of July 17, 2026

Top 10 Holdings

ZIQ
ASML Holding NV
7.28%
Novartis AG
4.43%
Roche Holding AG
4.40%
AstraZeneca PLC
4.02%
Nestlé SA
3.31%
BHP Group Ltd.
2.44%
Novo Nordisk A/S
2.28%
ABB Ltd.
2.26%
Tokyo Electron Ltd.
2.07%
Advantest Corp.
2.04%

Diversification

ZIQ
Total weight of top 10 holdings out of 219 total
34.54%

Characteristics

Compare
ZIQ
ProviderBMO
ManagementPassively managed
BenchmarkMSCI EAFE Quality NTR Index - CAD
Replication MethodDirect (Physical)
Asset ClassEquity
Dividend PolicyDistributing
Trailing 12m distribution yield1.48%
Meets ESG criteriaNo
Inception DateOctober 23, 2024
CboeTrackinsight
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.

All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
diamonds